Bioptik Technology Incorporation (4161)
Market Closed
10 Aug, 05:30
TWSE 
XSAU Primary TWSE NT$
23. 15
-0.55
-2.3207%
NT$
- Market Cap
31.2 P/E Ratio
0.4% Div Yield
60,296 Volume
0.18 Eps
NT$ 23.7
Previous Close Want to track 4161 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bioptik Technology Incorporation (4161) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.57B
Trailing P/E (ttm) 18.52
Forward P/E -
PEG ratio -0.67
Price/Sales (ttm) 1.64
Price/Book (mrq) 1.43
Enterprise Value/Revenue 1.82
Enterprise Value/EBITDA 13.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.09K
Average volume (90 days) 55.77K
Price summary
52-Week low 21.2
52-Week high 30.5
Beta -
50-Day moving average 22.77
200-Day moving average 24.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.7
Trailing annual dividend yield 0.0295%
5-Year annual dividend yield -
Payout ratio 0.22
Dividend Date 24 Sep 2025
Ex-Dividend Date 20 Aug 2025
Last split factor 1,130.04:1,000
Last split Date 20 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 15.16
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.49
Current ratio (mrq) 1.82%
Book value per share (mrq) 16.65
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
